RemeGen Co., Ltd.
OTC: REGMF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jianmin Fang
- Employees
- 2,999
- Headquarters
- Yantai, China
- IPO year
- 2021
- Market cap
- $6.8B
- Website
- https://www.remegen.com
Loading REGMF…
Loading profile data…Frequently asked questions about REGMF
What does RemeGen Co., Ltd. (REGMF) do?
RemeGen Co., Ltd., a biopharmaceutical firm established in Yantai, People's Republic of China, in 2008, focuses on the discovery, development, and commercialization of biologics. The company aims to address unmet medical needs in autoimmune, oncology, and ophthalmic diseases across Mainland China and the United States. Its commercial portfolio i...
Where does REGMF trade?
RemeGen Co., Ltd. (REGMF) trades on the Other OTC.
What sector is REGMF in?
RemeGen Co., Ltd. (REGMF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of RemeGen Co., Ltd.?
Jianmin Fang is the chief executive officer of RemeGen Co., Ltd. (REGMF).
Where is RemeGen Co., Ltd. headquartered?
RemeGen Co., Ltd. is headquartered in China.
Does REGMF pay a dividend?
RemeGen Co., Ltd. (REGMF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did REGMF go public?
RemeGen Co., Ltd. (REGMF) completed its initial public offering in 2021.